
Merck & Co., Inc. (MRK) Q4 2024 Earnings Call Transcript: Insights from the Pharmaceutical Giant’s Financial Performance Discussion
Merck & Co., Inc. (MRK) Q4 2025 Results Conference Call: A Detailed Analysis On February 4, 2025, Merck & Co., Inc. (MRK) held its Q4 2025 sales and earnings conference call. The call was led by Peter Dannenbaum, Senior Vice President of Investor Relations, and featured presentations from Rob Davis, Chairman and CEO; Caroline Litchfield,…